Dow Excipients

Articles

(Listed according to date in descending order)

pdf icon Scale-Up Trials of Foam-Granulation Technology--High Shear (579 KB PDF)
The authors evaluate the scalability of foam-granulation technology using continuous foam addition in high-shear granulation equipment at the laboratory, pilot, and manufacturing sites. Immediate- and controlled- release model formulations were used. Continuous and batch addition of foam work compared for the controlled-release model formulation at the manufacturing scale, and physical testing was performed on the granules and finished tablets.
pdf icon New Foamed Binder Technology from Dow Improves Granulation Process (795 KB PDF)

This article discusses our new foam binder technology -- what it is, its benefits, and supporting technical data.  The article was published in the June 2006 issue of Pharmaceutical Canada.


pdf icon Hypromellose, Ethylcellulose, and Polyethylene Oxide Use in Hot Melt Extrusion (198 KB PDF)

This six-page article was published in the January 2006 issue of Pharmaceutical Technology. The article reviews HME process parameters and highlights three polymers in HME (polyethylene oxide, ethylcellulose and hypromellose) to help you select the appropriate polymer for your HME formulation.


pdf icon Investigation of the Effect of Tablet Surface Area/Volume on Drug Release from Hydroxypropylmethylcellulose Controlled-Release Matrix Tablets (2 MB PDF)

This ten page article was originally published in Drug Development and Industrial Pharmacy in 2002. The purpose of this study was to investigate the influence of tablet surface area/volume (SA/Vol) on drug release from controlled-release matrix tablets containing hydroxypropylmethylcellulose (HPMC).


pdf icon A Compaction Process to Enhance Dissolution of Poorly Water-Soluble Drugs Using Hydroxypropyl Methylcellulose (Hypromellose) (704 KB PDF)

This is an eleven page article, which was originally published in the International Journal of Pharmaceutics. The purpose of this study was to develop a technique to enhance the dissolution rate of poorly water-soluble drugs with Hydroxypropyl Methylcellulose (Hypromellose) without the use of solvent or heat addition.


pdf icon Roll Compaction Granulation of a Controlled-Release Matrix Tablet Formulation Containing Hypromellose†: Effect of Process Scale-up on Robustness of Tablets, Tablet Stability, and Predicted In Vivo Performance (151 KB PDF)

This journal article, reprinted from the November 2000 issue of Pharmaceutical Technology, details a study of the effects on a theophylline controlled release formulation which is dry granulated in a laboratory-scale roller compactor and then scaled up to pilot-scale and to full production-scale. Physical property, drug dissolution, drug-release, and stability testing are thoroughly discussed.


pdf icon Roll Compaction Granulation of a Controlled-Release Matrix Tablet Formulation Containing Hypromellose†: Effect of Process Scale-up on Robustness of Tablets and Predicted In Vivo Performance (716 KB PDF)

This journal article, reprinted from a special insert on Tableting & Granulation from the October 1999 issue of Pharmaceutical Technology, details a study of the effects of roll compaction equipment scale-up on tablet robustness of a model matrix controlled-release formulation that contained hypromellose with theophylline as the model drug. The effects of scale-up from laboratory to pilot plant on granulation, tablet physical properties, and drug release of samples produced with roll compaction were compared with samples produced by direct compression.


pdf icon The Effects of Roll Compaction Equipment Variables, Granulation Technique and Hypromellose Polymer level on a Controlled-Release Matrix Model Drug Formulation (177 KB PDF)

This journal article, reprinted from Pharmaceutical Technology Europe, describes a study of the effects of roll compaction equipment variables, roll design, granulation technologies, and concentration of hypromellose polymer on the physical properties of a model controlled-release drug formulation. This article also appeared in Pharmaceutical Technology in March 1999.


pdf icon Comparison of Low-Shear and High-Shear Wet Granulation Techniques and the Influence of Percent Water Addition in the Preparation of a Controlled-Release Matrix Tablet Containing Hypromellose and a High-Dose, Highly Water-Soluble Drug (180 KB PDF)

This eight-page report was originally published in Pharmaceutical Technology magazine. The authors studied the effects of granulation technique and water addition levels on the physical properties of, and subsequent drug release from, tablets made from a controlled-release matrix formulation containing hypromellose and a high-dose, highly water-soluble drug (niacinamide). The results indicated that the level of water addition and the method of wet granulation (low shear versus high shear) had little effect on tablet physical properties and drug release. However, increasing levels of water addition resulted in increasing densification of granules. (March 1996)


pdf icon Evaluation of Various Polymers As Dry Binders in the Preparation of an Immediate-Release Tablet Formulation by Roller Compaction (167 KB PDF)

This 12-page article, which originally appeared in Pharmaceutical Technology magazine, describes an evaluation of nine commonly used polymers as dry binders for the manufacture of an immediate-release (IR) niacinamide tablet formulation using a roller compaction (dry granulation) process. Polymers studied were one methylcellulose, three hypromellose, two polyvinylpyrolidones, one pregelatinized cornstarch, and one microcrystalline cellulose. The study includes evaluations of tablet hardness and friability; granule particle sizes; and drug release rates for each of the polymers at three different levels. (October 1995)


pdf icon Effects of Lubricant Level, Method of Mixing, and Duration of Mixing on a Controlled-Release Matrix Tablet Containing Hypromellose (136 KB PDF)

Reprinted from Drug Development and Industrial Pharmacy, this 8-page article explores the effects of the lubricant magnesium stearate at different concentrations, mixing shear rates, and mixing times on the tablet properties and drug dissolution from controlled-release matrix tablets containing hypromellose 2208, USP, (METHOCEL K4M Premium). Studies were performed on diphenhydramine HCl and hydrochlorothiazide model drug formulations using spray-dried lactose and anhydrous dibasic calcium phosphate as the model excipient/fillers. The article provides data on resulting particle size distributions, crush strengths, friabilities, and dissolution characteristics of the various formulations. (1995)


pdf icon Use of Roller Compaction in the Preparation of Controlled-Release Hydrophilic Matrix Tablets Containing Methylcellulose and Hypromellose Polymers (121 KB PDF)

This journal article, reprinted from Pharmaceutical Technology, describes a study of roller compaction effects in the dry granulation of a controlled release matrix formulation containing methylcellulose or hypromellose. The authors evaluated the effect of roller compaction variables on tablet physical characteristics and drug-release profiles. Detailed charts show the results. (September 1994)


pdf icon Hansen Solubility Parameters for Selected Cellulose Ether Derivatives and Their Use in Pharmaceutical Industry (81 KB PDF)

This paper describes a laboratory method used for determining the partial solubility parameters of five METHOCEL* and six ETHOCEL* cellulose ether products. These laboratory derived values extend the data base of solubility parameters that have been used to understand phenomena like film coating adhesion, and cohesive and adhesive forces between substrates and polymeric binders in wet granulation processes. The paper characterizes the cellulose ethers in terms of non-polar, polar, and hydrogen bonding behavior. (1992)


pdf icon Thermal Gelation Properties of Methylcellulose and Hypromellose* (4 MB PDF)

Aqueous solutions of methylcellulose and hypromellose are known to form reversible gels upon heating. In pharmaceutical applications, gelation and gel strength of these products find use in tablet coating and in the manufacture of medicinal capsules. This 16-page article, which originally appeared in The Journal of Polymer Science, provides an in-depth review of the thermal gelation phenomenon and the factors that influence it, including polymer molecular weight, degree of substitution, and the effects of additives. (1979)


pdf icon Granulation with Dow Cellulosic Polymers I. Fluid Bed Granulation (460 KB PDF)

A 24-page technical article that details model studies for fluid bed granulation using METHOCEL Premium products as binders. Performance of METHOCEL Premium cellulosic polymers in three model systems is reported. Numerous charts portray granulation properties, dissolution rates, friability and hardness measures, and other results from tests on model formulations. (Last Printed January 2001)


pdf icon Granulation with Dow Cellulosic Polymers II. High Shear Granulation (717 KB PDF)

A 26-page technical article that details model studies for high shear granulation using METHOCEL Premium products as binders. Performance of METHOCEL Premium cellulose polymers in three model systems is reported. Numerous charts portray granulation properties, dissolution rates, friability and hardness measures, and other results from tests on model formulations. (Last Printed January 2001)


pdf icon Granulation with Dow Cellulosic Polymers III. Low Shear Granulation (317 KB PDF)

This 28-page brochure reports on in-depth studies of the performance of various binder polymers in three model systems produced by low shear granulation. Polymers studied are methylcellulose, hypromellose, hydroxypropyl cellulose, povidones, acacia, and pregelatinized starch. The three model drug systems included acetaminophen (high-dose, low solubility), Vitamin C (high-dose, high solubility), and methazolamide (low-dose, low solubility). The study reports on many performance variables, including particle size distributions of the granulates, tablet hardnesses and friabilities, and tablet dissolution properties. (Last Printed May 1996)


pdf icon Reworkability of Sustained-Release Tablet Formulations Containing Hypromellose Polymers (114 KB PDF)

Originally published in Pharmaceutical Technology magazine, this article evaluates the ability of sustained-release tablet matrix systems containing hypromellose to physically withstand the mechanical processes involved in a reworking procedure. The article covers the influence of polymer chemistry (substitution), the rework procedure, powder reblending levels, and the compression force on particle size distribution, tablet friability, and tablet hardness characteristics. Also investigated were the impact of the milling, remixing, and recompression processes on the in vitro drug-release dissolution profiles for three model drugs: ascorbic acid, chlorpheniramine maleate, and meclizine dihydrochloride. (Last Printed March 2000)



< back


Previously referred to as hydroxypropyl methylcellulose or HPMC


®™*Trademark of The Dow Chemical Company ("Dow") or an affiliated company of Dow.